Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

The mRNA platform is under investigation in many vaccines, including HIV-1 vaccines. While the mechanism behind urticarial reactions with these investigational HIV-1 mRNA vaccines is currently ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

mRNA is incredibly delicate ... Protiva found that one of its experimental LNP therapies caused a more severe immune reaction in humans than it had in the lab, and the company pinned pegylated ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know. Moderna met analysts’ revenue expectations last ...

Urticarial reactions, mostly transient, have been reported with both licensed mRNA COVID-19 vaccines. The study is published in Annals of Internal Medicine. An editorial on the trial results is ...